Delving into the Latest Updates on Smallpox vaccine (Lister vaccinia strain) (sanofi pasteur) with Synapse

Overview

Basic Info

Drug Type

Prophylactic vaccine

Synonyms

Smallpox VV Lister/CEP vaccine sanofi pasteur, VV LISTER/CEP

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Infectious Diseases

Active Indication

Smallpox

Inactive Indication-

Originator Organization

Sanofi Pasteur SA

Active Organization

Sanofi Pasteur SA

Inactive Organization

Sanofi

License Organization-

Drug Highest PhaseApproved

First Approval Date

United Kingdom (20 Jan 2009),

Smallpox

Regulation-

Login to view timeline

Although there is presently no definitive evidence linking vaccinia virus transmission through reproductive cells, SART/ASRM accordingly recommends that ART practitioners consider deferring donors who have recently received smallpox vaccine or contracted symptomatic vaccinia virus infection through close contact with a vaccine recipient (until after the vaccine or infectious scab has spontaneously separated). Good donor practice further suggests that donors who are not in good health, including those with recent complications from smallpox vaccine, should be similarly deferred.

01 Nov 2006·Fertility and SterilityQ2 · MEDICINE

Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus)

Q2 · MEDICINE

Review

Although there is presently no definitive evidence linking vaccinia virus transmission through reproductive cells, SART/ASRM accordingly recommends that ART practitioners consider deferring donors who have recently received smallpox vaccine or contracted symptomatic vaccinia virus infection through close contact with a vaccine recipient (until after the vaccine or infectious scab has spontaneously separated). Good donor practice further suggests that donors who are not in good health, including those with recent complications from smallpox vaccine, should be similarly deferred.

01 Sep 2004·Fertility and SterilityQ2 · MEDICINE

Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus)

Q2 · MEDICINE

Review

Although there is presently no definitive evidence linking vaccinia virus transmission through reproductive cells, SART/ASRM accordingly recommends that assisted reproductive technology (ART) practitioners consider deferring donors who have recently received smallpox vaccine or contracted symptomatic vaccinia virus infection through close contact with a vaccine recipient (until after the vaccine or infectious scab has spontaneously separated). Good donor practice further suggests that donors who are not in good health, including those with recent complications from smallpox vaccine, should be similarly deferred.

100 Deals associated with Smallpox vaccine (Lister vaccinia strain) (sanofi pasteur)

Login to view more data